KMI vs SABSW · P/E 24, rev $9.30B vs P/E 0.0
Kinder Morgan Inc (KMI) versus SAB Biotherapeutics Inc (SABSW) — a side-by-side from cached financials, not a winner call.
Kinder Morgan Inc (KMI) is a oil & gas midstream company listed on US.
SAB Biotherapeutics Inc (SABSW) common stock listed on NASDAQ.
Latest reported KMI revenue for 2026-06-30 was $9.30B. Net income was $1.84B. Revenue was up 92.7% from 2026-03-31 to 2026-06-30. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
SABSW does not have a complete income-statement cache yet.
KMI currently screens at market cap $62.53B and trailing P/E 24.2. SABSW currently screens at market cap $0 and trailing P/E 0.0.
Not investment advice. Open the KMI and SABSW stock pages for the full models.
Not investment advice.